BFEC
PGEN icon

Benjamin F. Edwards & Company’s Precigen PGEN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$1K – 1661
2017
Q4 		$1K Hold
100
– – ﹤0.01% 1542
2017
Q3 		$2K Buy
+100
New +$2.06K ﹤0.01% 1454

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Benjamin F. Edwards & Company's PGEN Position: Q1 2018 in Review

Benjamin F. Edwards & Company sold out of Precigen (PGEN) in Q1 2018, closing a stake of 100 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in PGEN in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q3 2017. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2018.

  • Benjamin F. Edwards & Company reported no remaining Precigen position as of Q1 2018 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 100 Precigen shares in Q1 2018, an estimated $1K.
  • Benjamin F. Edwards & Company first reported a position in Precigen in Q3 2017 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's Precigen position peaked at $2K in Q3 2017.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q1 2018.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2018, filed 17 Apr 2018.